key: cord-0776621-pt7fkx4b authors: Frezza, Daniele; Fabbris, Cristoforo; Franz, Leonardo; Vian, Elisa; Rigoli, Roberto; De Siati, Rosalba; Emanuelli, Enzo; Bertinato, Luigi; Boscolo‐Rizzo, Paolo; Spinato, Giacomo title: A Severe Acute Respiratory Syndrome Coronavirus 2 detection method based on nasal and nasopharyngeal lavage fluid: A pilot feasibility study date: 2021-07-27 journal: Laryngoscope Investig Otolaryngol DOI: 10.1002/lio2.625 sha: f174e4b940dd9c70dee950ddf13cd831cfc1011a doc_id: 776621 cord_uid: pt7fkx4b OBJECTIVE: Nose and nasopharyngeal swab is the preferred and worldwide‐accepted method to detect the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) within the nose and nasopharynx. This method may be linked with possible difficulties, such as patient's discomfort or complications. This article shows a pilot study of SARS‐CoV‐2 detection with nasal and nasopharyngeal lavage fluids (level of evidence: 3). METHODS: Nasal lavage fluid was collected from patients who were submitted to SARS‐CoV‐2 screening test, due to a preceding positive rapid antigen test. A control group was enrolled among health care professionals whose nasopharyngeal swab tested negative. Nasal lavages were performed using isotonic saline solution injected through a nasal fossa. Both lavage fluid and traditional nasopharyngeal swab were analyzed by real‐time (RT) PCR and antigenic test. RESULTS: A total of 49 positive subjects were enrolled in the study. Results of the analysis on lavages and nasopharyngeal swabs were concordant for 48 cases, regardless of the antigenic and molecular test performed. RT‐PCR resulted weakly positive at swab in one case and negative at lavage fluid. Among the control group (44 subjects), nasopharyngeal swab and lavage fluid analyses returned a negative result. Sensitivity of the molecular test based on nasal lavage fluid, compared to traditional nasal swab, was 97.7%, specificity was 100%, and accuracy was 98.9%, with high agreement (Cohen's κ, 0.978). CONCLUSION: Nasal and nasopharyngeal lavages resulted to be highly reliable and well tolerated. A larger series is needed to confirm these results. This approach may potentially represent a valid alternative to the traditional swab method in selected cases. LEVEL OF EVIDENCE: 3. Methods: Nasal lavage fluid was collected from patients who were submitted to SARS-CoV-2 screening test, due to a preceding positive rapid antigen test. A control group was enrolled among health care professionals whose nasopharyngeal swab tested negative. Nasal lavages were performed using isotonic saline solution injected through a nasal fossa. Both lavage fluid and traditional nasopharyngeal swab were analyzed by real-time (RT) PCR and antigenic test. Results: A total of 49 positive subjects were enrolled in the study. Results of the analysis on lavages and nasopharyngeal swabs were concordant for 48 cases, regardless of the antigenic and molecular test performed. RT-PCR resulted weakly positive at swab in one case and negative at lavage fluid. Among the control group (44 subjects), nasopharyngeal swab and lavage fluid analyses returned a negative result. Sensitivity of the molecular test based on nasal lavage fluid, compared to traditional nasal swab, was 97.7%, specificity was 100%, and accuracy was 98.9%, with high agreement (Cohen's κ, 0.978). Conclusion: Nasal and nasopharyngeal lavages resulted to be highly reliable and well tolerated. A larger series is needed to confirm these results. This approach may potentially represent a valid alternative to the traditional swab method in selected cases. The present work was performed at Treviso General Hospital, Treviso, Italy. The current pandemic related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 (COronaVIrus Disease 2019), requires massive population testing, and rises some issues regarding diagnostic accuracy and feasibility on large scale of the current sample collection techniques. As it has been shown, samples from nasopharynx have the highest chances to contain material suitable for SARS-CoV-2 detection. 1 Accordingly, nasopharyngeal swab is currently the first choice for SARS-CoV-2 infection diagnosis. 2 However, it requires a steep learning curve for health care providers and is operator-dependent. Indeed, the diagnostic accuracy of nasopharyngeal swabs depends on their success in reaching the nasopharynx. Such procedure may be affected by both poor performing technique (also due to anatomical misconception) and morphological barriers in the route to nasopharynx (including septal deviation), leading to increased discomfort during procedure. 3 Patient's compliance to nasopharyngeal swabs is critical, especially in planning massive population-based testing campaigns. Nasopharyngeal swab is not completely devoid of adverse events risk, like epistaxis, septal hematoma or abscess, retention of foreign bodies from broken swabs, or even cerebrospinal fluid leak. 4, 5 Possible mistakes among health care professionals deriving from long-lasting sessions of swab procedures must be also considered, with relative consequences on reliability of results. 6 Therefore, alternatives to the traditional swab should be developed to collect nasopharyngeal samples. Collection of lavage fluid has long been employed as a technique to obtain biological samples from the lower respiratory tract. The aim of this study was to preliminarily explore the feasibility and accuracy of nasal lavage as a method to collect samples from the nasopharynx for SARS-CoV-2 detection. The present study was approved by the ethics committee of Treviso and Belluno provinces (ethic vote: 871/CESC). Written informed consent was obtained by all participants enrolled in the study. We collected nasal lavage fluid from patients submitted to SARS-CoV-2 screening test who were positive on the first rapid antigen test performed on a nasopharyngeal swab and returned to the Treviso SARS-CoV-2 Screening Center to perform the confirmatory PCR-based test. A control group was enrolled among health care professionals whose nasopharyngeal swab tested negative. Each patient underwent the standard nasopharyngeal swab for molecular analysis. Immediately after swabbing, nasal lavages were performed using isotonic saline solution injected through a nasal fossa with device Lavonase Lab (Purling, Lugo di Romagna, Italy). The solution, mixed with nasal and nasopharyngeal secretions, once evacuated from the other nostril, was collected directly in a sterile tube (details are shown in Figures 1 and 2) . After nasopharyngeal swab and nasal lavage collection, each participant was asked to report their perception of procedure discomfort by a 100 mm Visual Analogic Scales (VAS), ranging from 0 (no discomfort) to 100 (maximal discomfort). All results are reported in Overall, nasal lavage fluid collection was atraumatic and well tolerated with no adverse events. Collection of the lavage was performed twice in two patients because they did not sufficiently bend their head. Patients reported much lower discomfort with nasal lavage (median VAS: 0; interquartile range: 0-16) than with nasopharyngeal swab (median VAS: 68; interquartile range: 31-85; P < .0001). The diagnosis of SARS-CoV-2 infection based on RT-PCR from nasopharyngeal nasal lavage was observed to be both feasible and accurate with specificity and sensitivity being 97.7% and 100%, respectively, when compared with the gold standard PCR from nasopharyngeal swab. The use of nasal lavage overcomes the critical issues risen by traditional nasopharyngeal swabs. First of all, such approach is easier to perform and more standardized, reducing the training time for the operators or it can be performed by patients themselves with reduction of the risk of contagion of COVID-19 for the operators and reduction of health costs. Time needed to prepare the devices and to collect nasopharyngeal specimens is comparable between lavages and swabs. Moreover, issues related to collection, transport, and storage could be greatly reduced. 7 Lavages might also allow to obtain sufficient nasopharyngeal material even from anticoagulated patients or from those with severe septal deviation or with reduced compliance (like pediatric or non-cooperative subjects). For instance, regarding pediatric patients, there are no differences with the everyday clinical and home practice, since nasal lavages are routinely performed. Also, it must be born in mind that some patients may have nasal diseases (eg, chronic rhinosinusitis and nasal polyps): in these cases, the use of the swab could be very uncomfortable or it can collect a large amount of nasal secretions that may whitewash results and give false negatives. Some other patients may have previously undergone surgical procedures (eg, transnasal skull base surgery with reconstruction), thus the use of the swab would be recommended only to specialists, whereas nasal lavages would not be dangerous at all (being them usually suggested post-operatively to prevent crusting). Moreover, lavages avoid direct contact of a swab with nasal and nasopharyngeal mucosa. This is not only a compliance issue: nasal mucosa brushing, besides producing discomfort, damages the muco-ciliary clearance system, which may take several weeks to be repaired 8 F I G U R E 2 Example of the use of the device. A syringe is filled with isotonic sterile fluid (10 cc) and located on the right part of the device. The top of the syringe is linked with a cone-shaped rubber dispenser. The collection tube is inserted at the bottom in the left part. The patient bends down his head onto the device and introduces the top of the dispenser in his right nostril for a few millimeters. Then, he presses the plunger so that the fluid passes into the right nasal fossa, the nasopharynx, and the left nasal fossa. At the end, the fluid exits the left nasal fossa and collects into the test tube T A B L E 1 Distribution of SARS-CoV-2 positive and negative cases among nasal swabs and lavages According to the present pilot clinical study, nasal and nasopharyngeal lavages resulted to be highly reliable and well-tolerated, even if the research was conducted among a small case series. Further studies among a larger number of positive and negative subjects is needed to confirm these results. If these aspects will be confirmed, diagnosis based on nasal and nasopharyngeal lavage fluid may potentially represent a valid alternative to the traditional swab method. Additional supporting information may be found online in the Supporting Information section at the end of this article. Necessity for detection of SARS-CoV-2 RNA in multiple types of specimens for the discharge of the patients with COVID-19 Risk management during COVID-19: safety procedures for otolaryngologists SARS-CoV-2 nasopharyngeal swab testing-false-negative results from a pervasive anatomical misconception Is oro/nasopharyngeal swab for SARS-CoV-2 detection a safe procedure? Complications observed among a case series of 4876 consecutive swabs Cerebrospinal fluid leak after nasal swab testing for coronavirus disease Interim guidance for the appropriate support of the health workers in the SARS-CoV-2 emergency scenario. Version May 28, 2020. ISS Working Group Mental health and emergency COVID-19 2020, 14 p Recommendations for collection, transport and storage of COVID-19 biological samples. Version of April 15, 2020. ISS COVID-19 Translational Research Working Group Cytofunctional changes in nasal ciliated cells in patients treated with hyaluronate after nasal surgery The authors would like to acknowledge Jerry Polesel for his support in statistical analysis of the data.